Alzheimer disease trials in Colombia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Dominantly Inherited Alzheimer Network (DIAN)

  Where

  Medellín

  Age

  18 years and over

  People

  700 worldwide

  Run by

  Washington University School of Medicine

  See details and how to joinNCT00869817
• Phase 2/3Taking people
  A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease

  Where

  Medellín

  Age

  25 years to 65 years

  People

  240

  Run by

  Banner Health

  See details and how to joinNCT06996730
• Phase 2/3Taking people
  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  Where

  Medellín

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Washington University School of Medicine

  See details and how to joinNCT05552157
• Phase 2/3Taking people
  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  Where

  Medellín

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Washington University School of Medicine

  See details and how to joinNCT06647498